$CNAT merger vote on May 21, additionally Histogen, their merger partner just got FDA IND approval to start trials. I really like this play for .75-1.00 area. The float is tight and really has not received the volume all these other merger plays are getting. 12-15m volume and I think it will double or better.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.